Smart Pharma regards formulation innovation as its driving force and core competency. The Company specializes in advanced drug delivery system (DDS) to develop patented new drugs to improve clinical efficacy, in order to help patients alleviate their pain and improve their quality of life. Our pipeline targets many areas of chronic diseases, such as cardiovascular and cerebrovascular diseases, tumor, mental illness, diabetes, gastrointestinal disorder, pain and infections. Our market is mainly in Europe, the United States, Japan and Greater China.
Prof. Odidi has hundreds of patents approved in countries such as the United States, Canada, EU, China, Japan and India. There are more than 200 patents worldwide cited from Prof. Odidi’s technology.
Our R&D team consists of scientists and engineers from the United States, Canada, India and China. Several core team members have worked in the world’s top 50 pharmaceutical companies and have an extensive experience with R&D, management...
In December 2019, Smart Pharma Suzhou invested over¥30 million and established a top notch R&D center in accordance with FDA standards in Taicang Biomedical Industrial Park.
"onGPS" is a newly developed technology platform that is built by using complex multivariate API delivery and targeting systems made with multiple polymeric or non-polymer functional materials to improve the solubility of the APIs that...
Our mastery of pharmacology allows us to design and develop broad-spectrum smart drugs for a variety of indications, such as cardio-cerebrovascular, psychiatric, diabetes, gastrointestinal, pain, and infection treatment areas.
If you are a responsible partner, good and pure big children, love life love work active molecules, have an ideal and ambitious young people, talented witty witty year, focus and witty love smile outstanding students. Welcome to the following positions!